This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://jaguargenetherapy.com/press-release/jaguar-gene-therapy-announces-successful-completion-of-dosing-of-first-patient-cohort-in-clinical-trial-evaluating-jag201-for-the-treatment-of-a-leading-monogenic-cause-of-autism-spectrum-disorder-kno/